vs
Side-by-side financial comparison of GSI TECHNOLOGY INC (GSIT) and MAXCYTE, INC. (MXCT). Click either name above to swap in a different company.
GSI TECHNOLOGY INC is the larger business by last-quarter revenue ($6.1M vs $4.8M, roughly 1.3× MAXCYTE, INC.). GSI TECHNOLOGY INC runs the higher net margin — -49.7% vs -200.5%, a 150.8% gap on every dollar of revenue. On growth, GSI TECHNOLOGY INC posted the faster year-over-year revenue change (12.2% vs -20.9%). MAXCYTE, INC. produced more free cash flow last quarter ($-2.9M vs $-8.2M). Over the past eight quarters, GSI TECHNOLOGY INC's revenue compounded faster (8.6% CAGR vs -7.4%).
Triad GSI is an American voting machine vendor based in Xenia, Ohio. Their main products are election-related computer hardware and software for counting ballots, as well as voter registration.
MaxCyte Inc. is a global biotechnology company focused on developing cell engineering platforms and enabling technologies for cell and gene therapy advancement. Its proprietary non-viral cell modification systems are widely used by pharmaceutical, biotech and life science research entities to develop immunotherapies, gene-edited treatments and next-generation biologic drugs from preclinical research through commercialization.
GSIT vs MXCT — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $6.1M | $4.8M |
| Net Profit | $-3.0M | $-9.6M |
| Gross Margin | 52.7% | — |
| Operating Margin | -113.7% | -234.5% |
| Net Margin | -49.7% | -200.5% |
| Revenue YoY | 12.2% | -20.9% |
| Net Profit YoY | 25.0% | 9.4% |
| EPS (diluted) | $-0.09 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $6.1M | $4.8M | ||
| Q3 25 | $6.4M | $4.6M | ||
| Q2 25 | $6.3M | $5.8M | ||
| Q1 25 | $5.9M | $5.7M | ||
| Q4 24 | $5.4M | $6.1M | ||
| Q3 24 | $4.5M | $5.6M | ||
| Q2 24 | $4.7M | $5.0M | ||
| Q1 24 | $5.2M | $5.6M |
| Q4 25 | $-3.0M | $-9.6M | ||
| Q3 25 | $-3.2M | $-12.4M | ||
| Q2 25 | $-2.2M | $-12.4M | ||
| Q1 25 | $-2.2M | $-10.3M | ||
| Q4 24 | $-4.0M | $-10.6M | ||
| Q3 24 | $-5.5M | $-11.6M | ||
| Q2 24 | $1.1M | $-9.4M | ||
| Q1 24 | $-4.3M | $-9.5M |
| Q4 25 | 52.7% | — | ||
| Q3 25 | 54.8% | — | ||
| Q2 25 | 58.1% | — | ||
| Q1 25 | 56.1% | — | ||
| Q4 24 | 54.0% | — | ||
| Q3 24 | 38.6% | — | ||
| Q2 24 | 46.3% | — | ||
| Q1 24 | 51.6% | — |
| Q4 25 | -113.7% | -234.5% | ||
| Q3 25 | -49.5% | -307.4% | ||
| Q2 25 | -34.6% | -244.3% | ||
| Q1 25 | -38.7% | -214.1% | ||
| Q4 24 | -74.9% | -213.1% | ||
| Q3 24 | -122.7% | -250.4% | ||
| Q2 24 | 23.1% | -241.0% | ||
| Q1 24 | -87.6% | -219.8% |
| Q4 25 | -49.7% | -200.5% | ||
| Q3 25 | -49.4% | -269.7% | ||
| Q2 25 | -35.3% | -212.2% | ||
| Q1 25 | -37.9% | -178.7% | ||
| Q4 24 | -74.4% | -175.0% | ||
| Q3 24 | -120.0% | -205.9% | ||
| Q2 24 | 23.1% | -188.8% | ||
| Q1 24 | -83.9% | -170.6% |
| Q4 25 | $-0.09 | — | ||
| Q3 25 | $-0.11 | $-0.12 | ||
| Q2 25 | $-0.08 | $-0.12 | ||
| Q1 25 | $-0.09 | — | ||
| Q4 24 | $-0.16 | — | ||
| Q3 24 | $-0.21 | $-0.11 | ||
| Q2 24 | $0.04 | $-0.09 | ||
| Q1 24 | $-0.17 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $70.7M | $103.0M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $83.6M | $171.5M |
| Total Assets | $98.5M | $202.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $70.7M | $103.0M | ||
| Q3 25 | $25.3M | $105.7M | ||
| Q2 25 | $22.7M | $126.6M | ||
| Q1 25 | $13.4M | $138.3M | ||
| Q4 24 | $15.1M | $154.5M | ||
| Q3 24 | $18.4M | $153.8M | ||
| Q2 24 | $21.8M | $157.3M | ||
| Q1 24 | $14.4M | $157.5M |
| Q4 25 | $83.6M | $171.5M | ||
| Q3 25 | $38.6M | $180.3M | ||
| Q2 25 | $37.4M | $190.7M | ||
| Q1 25 | $28.2M | $199.4M | ||
| Q4 24 | $29.9M | $206.3M | ||
| Q3 24 | $33.3M | $213.3M | ||
| Q2 24 | $38.0M | $221.3M | ||
| Q1 24 | $36.0M | $226.4M |
| Q4 25 | $98.5M | $202.5M | ||
| Q3 25 | $52.0M | $213.5M | ||
| Q2 25 | $50.5M | $219.8M | ||
| Q1 25 | $43.3M | $230.0M | ||
| Q4 24 | $44.1M | $239.5M | ||
| Q3 24 | $47.4M | $248.6M | ||
| Q2 24 | $52.3M | $251.5M | ||
| Q1 24 | $42.5M | $257.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-7.9M | $-2.7M |
| Free Cash FlowOCF − Capex | $-8.2M | $-2.9M |
| FCF MarginFCF / Revenue | -134.4% | -61.0% |
| Capex IntensityCapex / Revenue | 4.9% | 4.8% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-12.5M | $-36.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-7.9M | $-2.7M | ||
| Q3 25 | $-887.0K | $-7.5M | ||
| Q2 25 | $-1.7M | $-9.9M | ||
| Q1 25 | $-1.7M | $-14.4M | ||
| Q4 24 | $-3.6M | $-7.8M | ||
| Q3 24 | $-3.5M | $-4.4M | ||
| Q2 24 | $-4.3M | $-4.8M | ||
| Q1 24 | $-7.1M | $-10.6M |
| Q4 25 | $-8.2M | $-2.9M | ||
| Q3 25 | $-906.0K | $-7.8M | ||
| Q2 25 | $-1.7M | $-10.4M | ||
| Q1 25 | $-1.7M | $-15.1M | ||
| Q4 24 | $-3.6M | $-8.0M | ||
| Q3 24 | $-3.5M | $-4.8M | ||
| Q2 24 | $-4.3M | $-5.1M | ||
| Q1 24 | $-7.2M | $-11.4M |
| Q4 25 | -134.4% | -61.0% | ||
| Q3 25 | -14.1% | -168.5% | ||
| Q2 25 | -27.6% | -179.2% | ||
| Q1 25 | -28.3% | -262.3% | ||
| Q4 24 | -66.1% | -131.6% | ||
| Q3 24 | -76.6% | -85.5% | ||
| Q2 24 | -92.0% | -103.3% | ||
| Q1 24 | -139.0% | -203.6% |
| Q4 25 | 4.9% | 4.8% | ||
| Q3 25 | 0.3% | 6.5% | ||
| Q2 25 | 0.3% | 10.0% | ||
| Q1 25 | 0.1% | 11.4% | ||
| Q4 24 | 0.1% | 2.4% | ||
| Q3 24 | 0.1% | 7.2% | ||
| Q2 24 | 0.7% | 5.9% | ||
| Q1 24 | 0.2% | 14.4% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -3.96× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GSIT
| Distribution | $5.6M | 92% |
| Other | $459.0K | 8% |
MXCT
| Products | $4.2M | 87% |
| Other | $634.0K | 13% |
